Atheromed Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 18

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $132M

Atheromed General Information

Description

Developer of catheter-based medical devices intended for the treatment of peripheral artery disease (PAD). The system is designed to treat vessel diameters from the small vessels at the ankle up to the larger vessels located above the knee, thereby helping patients with their treatments.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1455 Adams Drive
  • Suite 1120
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Surgical Devices
Vertical(s)
Corporate Office
  • 1455 Adams Drive
  • Suite 1120
  • Menlo Park, CA 94025
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atheromed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 19-Jun-2014 $132M Completed Generating Revenue
6. Later Stage VC 10-Dec-2013 Completed Generating Revenue
5. Later Stage VC (Series D) 02-Apr-2013 Completed Generating Revenue
4. Later Stage VC (Series C) 21-Mar-2012 Completed Generating Revenue
3. Later Stage VC (Series B1) 06-May-2011 Completed Generating Revenue
2. Early Stage VC (Series B) 20-Oct-2009 $2.36M $9.4M Completed Generating Revenue
1. Early Stage VC (Series A) 02-Jan-2008 $7.04M $7.04M Completed Product Development
To view Atheromed’s complete valuation and funding history, request access »

Atheromed Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B1
Series B
Series A1 4,001,381 $0.000100 $0.06 $0.77 $0.77 1x $0.49 5.19%
Series A 427,605 $0.000100 $0.06 $0.77 $0.77 1x $0.49 0.55%
To view Atheromed’s complete cap table history, request access »

Atheromed Patents

Atheromed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160242808-A1 Atherectomy apparatus with imaging Active 20-Feb-2015
EP-3027126-A2 Atherectomy devices Active 31-Jul-2013
EP-3027126-A4 Atherectomy devices Active 31-Jul-2013
EP-3027126-B1 Atherectomy devices Active 31-Jul-2013
US-20150150587-A1 Atherectomy devices Active 31-Jul-2013 A61B17/320758
To view Atheromed’s complete patent history, request access »

Atheromed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atheromed Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Canaan Partners Venture Capital Minority
Kaiser Permanente Ventures Corporate Venture Capital Minority
MC Silicon Valley Corporation Minority
Monte Savello Venture Capital Minority
SPi Hawaii Investment Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Atheromed FAQs

  • When was Atheromed founded?

    Atheromed was founded in 2006.

  • Where is Atheromed headquartered?

    Atheromed is headquartered in Menlo Park, CA.

  • What is the size of Atheromed?

    Atheromed has 18 total employees.

  • What industry is Atheromed in?

    Atheromed’s primary industry is Surgical Devices.

  • Is Atheromed a private or public company?

    Atheromed is a Private company.

  • What is the current valuation of Atheromed?

    The current valuation of Atheromed is .

  • What is Atheromed’s current revenue?

    The current revenue for Atheromed is .

  • How much funding has Atheromed raised over time?

    Atheromed has raised $37M.

  • Who are Atheromed’s investors?

    Canaan Partners, Kaiser Permanente Ventures, MC Silicon Valley, Monte Savello, and SPi Hawaii Investment are 5 of 8 investors who have invested in Atheromed.

  • When was Atheromed acquired?

    Atheromed was acquired on 19-Jun-2014.

  • Who acquired Atheromed?

    Atheromed was acquired by Philips Image Guided Therapy.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process